SMDAM
EW icon

Sumitomo Mitsui DS Asset Management’s Edwards Lifesciences EW Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.04M Buy
77,840
+960
+1% +$80.4K 0.05% 282
2026
Q1 		$6.16M Buy
76,880
+1,704
+2% +$140K 0.05% 281
2025
Q4 		$6.41M Buy
75,176
+797
+1% +$65.4K 0.05% 258
2025
Q3 		$5.78M Buy
74,379
+598
+0.8% +$46.7K 0.05% 280
2025
Q2 		$5.77M Buy
73,781
+1,521
+2% +$113K 0.05% 270
2025
Q1 		$5.24M Buy
72,260
+7,213
+11% +$516K 0.05% 273
2024
Q4 		$4.82M Sell
65,047
-13,902
-18% -$973K 0.05% 289
2024
Q3 		$5.21M Sell
78,949
-49,382
-38% -$3.59M 0.06% 262
2024
Q2 		$11.9M Buy
128,331
+4,382
+4% +$388K 0.14% 132
2024
Q1 		$11.8M Sell
123,949
-832
-0.7% -$69.9K 0.15% 131
2023
Q4 		$9.51M Sell
124,781
-10,491
-8% -$730K 0.12% 170
2023
Q3 		$9.37M Sell
135,272
-12,513
-8% -$1.01M 0.15% 133
2023
Q2 		$13.9M Buy
147,785
+23,072
+19% +$2.01M 0.21% 89
2023
Q1 		$10.3M Buy
124,713
+4,240
+4% +$333K 0.19% 99
2022
Q4 		$8.99M Buy
120,473
+1,254
+1% +$96.6K 0.18% 108
2022
Q3 		$9.85M Buy
119,219
+4,276
+4% +$411K 0.22% 84
2022
Q2 		$10.9M Buy
114,943
+5,394
+5% +$558K 0.26% 78
2022
Q1 		$12.9M Buy
109,549
+43,037
+65% +$4.83M 0.27% 76
2021
Q4 		$8.62M Buy
66,512
+2,006
+3% +$234K 0.18% 111
2021
Q3 		$7.3M Sell
64,506
-811
-1% -$92.6K 0.17% 116
2021
Q2 		$6.76M Sell
65,317
-2,843
-4% -$268K 0.16% 127
2021
Q1 		$5.7M Buy
68,160
+940
+1% +$79.5K 0.15% 140
2020
Q4 		$6.13M Buy
67,220
+11,614
+21% +$963K 0.17% 115
2020
Q3 		$4.44M Buy
55,606
+178
+0.3% +$13.9K 0.14% 134
2020
Q2 		$3.83M Buy
55,428
+1,608
+3% +$114K 0.13% 143
2020
Q1 		$3.38M Buy
53,820
+1,395
+3% +$101K 0.14% 137
2019
Q4 		$4.08M Sell
52,425
-8,319
-14% -$650K 0.14% 149
2019
Q3 		$4.45M Buy
60,744
+5,070
+9% +$356K 0.17% 132
2019
Q2 		$3.43M Sell
55,674
-5,613
-9% -$339K 0.14% 150
2019
Q1 		$3.91M Buy
61,287
+1,530
+3% +$87.3K 0.06% 233
2018
Q4 		$3.05M Buy
59,757
+16,038
+37% +$811K 0.06% 238
2018
Q3 		$2.54M Sell
43,719
-318
-0.7% -$15.6K 0.04% 319
2018
Q2 		$2.14M Buy
44,037
+288
+0.7% +$13.4K 0.03% 349
2018
Q1 		$2.03M Sell
43,749
-2,586
-6% -$112K 0.03% 361
2017
Q4 		$1.74M Sell
46,335
-1,551
-3% -$56.9K 0.03% 396
2017
Q3 		$1.74M Sell
47,886
-2,040
-4% -$77.8K 0.03% 360
2017
Q2 		$1.97M Sell
49,926
-2,283
-4% -$83.3K 0.03% 353
2017
Q1 		$1.64M Buy
52,209
+3,573
+7% +$112K 0.03% 372
2016
Q4 		$1.52M Sell
48,636
-792
-2% -$25.7K 0.03% 363
2016
Q3 		$1.99M Sell
49,428
-138
-0.3% -$5.2K 0.04% 318
2016
Q2 		$1.65M Buy
49,566
+669
+1% +$22.9K 0.05% 298
2016
Q1 		$1.44M Buy
48,897
+729
+2% +$20.1K 0.04% 310
2015
Q4 		$1.27M Sell
48,168
-1,266
-3% -$32.9K 0.04% 331
2015
Q3 		$1.17M Buy
49,434
+168
+0.3% +$4.05K 0.04% 357
2015
Q2 		$1.17M Sell
49,266
-3,246
-6% -$73.3K 0.04% 394
2015
Q1 		$1.25M Sell
52,512
-3,582
-6% -$80.4K 0.04% 398
2014
Q4 		$1.19M Sell
56,094
-3,348
-6% -$67.3K 0.04% 422
2014
Q3 		$1.01M Sell
59,442
-3,294
-5% -$52K 0.03% 482
2014
Q2 		$897K Sell
62,736
-9,510
-13% -$129K 0.03% 535
2014
Q1 		$893K Sell
72,246
-504
-0.7% -$5.82K 0.03% 539
2013
Q4 		$797K Sell
72,750
-12,306
-14% -$139K 0.02% 585
2013
Q3 		$987K Sell
85,056
-546
-0.6% -$6.39K 0.03% 495
2013
Q2 		$958K Buy
+85,602
New +$1.01M 0.03% 497

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's EW Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management increased its Edwards Lifesciences (EW) stake by 1.2% in Q2 2026, buying an estimated $80.4K and bringing the position to 77,840 shares worth $7.04M. The position accounts for 0.05% of the portfolio, ranked #282.

Sumitomo Mitsui DS Asset Management first reported a position in EW in Q2 2013 and has held it in 53 quarters since. The position peaked at $13.9M in Q2 2023. 372 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 77,840 shares of Edwards Lifesciences worth $7.04M as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management bought 960 Edwards Lifesciences shares in Q2 2026, an estimated $80.4K.
  • Edwards Lifesciences made up 0.05% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #282 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 53 quarters since.
  • Sumitomo Mitsui DS Asset Management's Edwards Lifesciences position peaked at $13.9M in Q2 2023.
  • 372 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.